These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Disinfectants as an aid for good manufacturing practice in the pharmaceutical industry. Wallhäusser KH J Pharm Belg; 1981; 36(5):283-97. PubMed ID: 7310623 [No Abstract] [Full Text] [Related]
47. [Elaboration of examination rules for initial substances and end products]. Hubmann E Pharm Acta Helv; 1973; 48(8):443-54. PubMed ID: 4766786 [No Abstract] [Full Text] [Related]
48. What is quality of medicines? Doogue MP; Thynne TR Intern Med J; 2013 Oct; 43(10):1057-8. PubMed ID: 24134167 [No Abstract] [Full Text] [Related]
49. Pharmaceutical controls for drug availability. Bethel RF Med Serv J Can; 1967 Mar; 23(3):337-45. PubMed ID: 6061040 [No Abstract] [Full Text] [Related]
50. [Changes in the norms governing practices for the manufacture of pharmaceutical products: implications for the MERCOSUR]. Temprano G; Prats S; Bregni C Boll Chim Farm; 1998 Nov; 137(10):426-38. PubMed ID: 9880947 [TBL] [Abstract][Full Text] [Related]
51. 3. Drug regulations in Switzerland and their application. Hippenmeier F Bull Parenter Drug Assoc; 1974; 28(4):167-73. PubMed ID: 4855448 [No Abstract] [Full Text] [Related]
52. Short communication: a study on the packaging information of essential drug products used at Union and Thana health complex level in Bangladesh. Amran S; Ahmed M; Shaheen SM; Morshed SN; Khandakar J; Rahman M; Rahman M; Hossain A Pak J Pharm Sci; 2007 Oct; 20(4):327-32. PubMed ID: 17604258 [TBL] [Abstract][Full Text] [Related]
53. Guidance for temperature-controlled medicinal products: maintaining the quality of temperature-sensitive medicinal products through the transportation environment. Parenteral Drug Association PDA J Pharm Sci Technol; 2007; 61(2 Suppl TR 39):2-19. PubMed ID: 17953229 [No Abstract] [Full Text] [Related]
54. Compounding and repackaging--a need for complete records. Proksch RA Hosp Pharm; 1980 Jul; 15(7):344-5, 349-50, 352-5. PubMed ID: 10247655 [TBL] [Abstract][Full Text] [Related]
55. Feasibility of unit dose packaging of medications for inhalation therapy. Talley JR; Magarian RA; Sommers EB Am J Hosp Pharm; 1973 Jun; 30(6):526-30. PubMed ID: 4709934 [No Abstract] [Full Text] [Related]
56. Microbial content in non-sterile pharmaceuticals. I. Introduction. Dan Tidsskr Farm; 1968; 42(1):1-4. PubMed ID: 4968767 [No Abstract] [Full Text] [Related]